Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 2.6/5
Imugene Ltd

Imugene Ltd (IMU AU)

63
Analysis
Health CareAustralia
Imugene Limited is a health biotechnology development company. The Company manufactures vaccines for gastric and breast cancer treatments. Imugene operates in Europe and Australia.
more
bullishImugene Ltd
13 Jan 2025 00:30

Imugene (IMU AU): Pipeline Progresses; Capital Injection to Extend Cash Runway to Late 2025

​Imugene dosed first Australian patient in Phase 1b trial for azer-cel in DLBCL. Azer-cel has potential to become blockbuster drug. Company plans...

Logo
364 Views
Share
29 Jun 2025 00:30

APAC Healthcare Weekly (June 29)- RemeGen, Innovent, Daiichi, SanBio, Otsuka, Chugai, Glenmark

Last week couple of Chinese companies signed outlicensing deals with international players. Innovent got weight loss drug approval in China....

Logo
469 Views
Share
08 Jun 2025 00:30

APAC Healthcare Weekly (June 8)- Hansoh Pharma, Daiichi Sankyo, Takeda, Mayne Pharma, Zydus Life

Hansoh stuck deal with Regeneron for obesity drug candidate. Daiichi Sankyo unveiled positive phase 3 trial result in first-line breast cancer....

Logo
660 Views
Share
06 Apr 2025 00:30

APAC Healthcare Weekly (April 6)- Nippon Shinyaku, Shionogi, Beigene, Celltrion, Mesoblast, Lupin

Nippon Shinyaku and Shionogi are filing for new drugs. Beigene dropped a phase 3 oncology asset. Mesoblast is about to start treatment with...

Logo
601 Views
Share
09 Mar 2025 20:00

S&P/​​​​ASX Index Rebalance (Mar 2025): SIG Is the BIG One; Changes Galore Across Indices

There are 40 constituent changes across the indices. SIG is an add to 2 indices and also an upweight in 2 others - so big buying. The adds have...

Logo
1.1k Views
Share
x